POZ New long-acting HIV treatment expands options for people troubled by taking daily pills, virus is resistant to common HIV drugs A new approach replaces rilpivirine with lenacapavir, a long-acting drug that attacks HIV in a different way. OutrageMag.com StaffOct 17, 2026
POZ Less frequent, all-injectable treatment for HIV is safe and preferred by adolescents Adolescents with HIV in Botswana, South Africa, Thailand, Uganda and the US who received the injectable intramuscular antiviral medications cabotegravir and rilpivirine after being... OutrageMag.com StaffFeb 13, 2026
POZ Antiretroviral agent such as rilpivirine could improve pre-exposure prophylaxis In an ex vivo model of HIV PrEP using tissue samples in the laboratory, the drug was associated with significant inhibition of HIV replication... OutrageMag.com StaffAug 1, 2019